NCT04389827Completed
Global Kidney Patient Trials Network
Source: ClinicalTrials.gov · Last updated 15 Dec 2025
Brief summary (registry, in English)
This is a prospective international multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 5999 (actual)
- First submitted
- 4 May 2020
- Start date
- 5 May 2020
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- The George Institute
- Diseases
- Chronic kidney disease, IgA nephropathy
- NCT number
- NCT04389827
What you commit to
- Study type: Observational
- Participants enrolled: 5999
- From 5 May 2020 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving renal replacement therapy or planned to start in the next 6 months
- Planned transplant in the next 6 months
Other
- Life-expectancy of less than 6 months
- Currently participating in a clinical trial involving investigational medicinal product (exception is participation in studies implemented through the GKPTN)
Who the study is looking for
- Documented diagnosis of primary kidney disease
- Regular visits (6-12 monthly) with a physician at a participating site that includes the monitoring of protein in urine and kidney function
- eGFR \> 25 ml/min/1.73m2
- ≥ 2 to ≥ 80 years of age
- One of the following laboratory urine parameters within 12 months of screening meeting the values of:
- Urine Albumin-to-Creatinine Ratio (UACR) \> 200 mg/g OR
- Protein-to-Creatinine Ratio (PCR) \> 300 mg/g OR
- Albumin Excretion Rate (AER) \> 200 mg/day OR
- 24 hour Albumin Excretion \> 200 mg/day OR
- 24 hour Urine Protein Excretion \> 300 mg/day
- Willing and able to sign informed consent
- Willing to be approached about participation in interventional research studies
Age in the registry: 2 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The George Institute Coordinator of this site? Confirm its status | Sydney | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.